Cornerstone Advisory’s Oscar Health OSCR Stock Holding History

Cornerstone Advisory’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-210	Closed	-$2K	–	606
2021 Q4	$2K	Buy	+210	New	+$2.64K	﹤0.01%	738

Other funds holding OSCR

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cornerstone Advisory's OSCR Position: Q1 2022 in Review

Cornerstone Advisory sold out of Oscar Health (OSCR) in Q1 2022, closing a stake of 210 shares — an estimated $2K sold.

Cornerstone Advisory first reported a position in OSCR in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 123 funds tracked by Wall St. Rank hold OSCR as of Q1 2022.

Cornerstone Advisory reported no remaining Oscar Health position as of Q1 2022 after selling out during the quarter.
Cornerstone Advisory sold 210 Oscar Health shares in Q1 2022, an estimated $2K.
Cornerstone Advisory first reported a position in Oscar Health in Q4 2021 and held it in 1 quarter.
Cornerstone Advisory's Oscar Health position peaked at $2K in Q4 2021.
123 funds tracked by Wall St. Rank held Oscar Health as of Q1 2022.

Based on Cornerstone Advisory's 13F filing for Q1 2022, filed 20 May 2022.